Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rashmi Chugh

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Cancer|May 7, 2014
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration studyAlberto S Pappo, Gilles Vassal, John J Crowley, et al.
Emerging Infectious Diseases|June 17, 2015
Lack of Transmission among Close Contacts of Patient with Case of Middle East Respiratory Syndrome Imported into the United States, 2014Lucy Breakwell, Kimberly Pringle, Nora Chea, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2026
A pooled analysis of phase 2 clinical trials in advanced chordomaGregory M Cote, Corrine F Elliott, Astrid Lipplaa, et al.
Cancer|October 4, 2016
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumorScott M Schuetze, Vanessa Bolejack, Edwin Choy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2025
Immunocompetent Murine Models Recapitulate the Heterogeneous Tumor-Immune Microenvironment of Human LiposarcomaAmanda M Shafer, Emma Kenna, Lexi-Ann F Golden, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2025
An immunocompetent mouse model of liposarcomaAmanda M Shafer, Emma Kenna, Lexi-Ann F Golden, et al.
JCO Precision Oncology|February 1, 2022
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR AlterationsDavid M Hyman, Ben Tran, Luis Paz-Ares, et al.
The Lancet. Oncology|October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket studyMrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
The New England Journal of Medicine|October 10, 2009
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009Seema Jain, Laurie Kamimoto, Anna M Bramley, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Cancer|May 7, 2014
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration studyAlberto S Pappo, Gilles Vassal, John J Crowley, et al.
Emerging Infectious Diseases|June 17, 2015
Lack of Transmission among Close Contacts of Patient with Case of Middle East Respiratory Syndrome Imported into the United States, 2014Lucy Breakwell, Kimberly Pringle, Nora Chea, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2026
A pooled analysis of phase 2 clinical trials in advanced chordomaGregory M Cote, Corrine F Elliott, Astrid Lipplaa, et al.
Cancer|October 4, 2016
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumorScott M Schuetze, Vanessa Bolejack, Edwin Choy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2025
Immunocompetent Murine Models Recapitulate the Heterogeneous Tumor-Immune Microenvironment of Human LiposarcomaAmanda M Shafer, Emma Kenna, Lexi-Ann F Golden, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2025
An immunocompetent mouse model of liposarcomaAmanda M Shafer, Emma Kenna, Lexi-Ann F Golden, et al.
JCO Precision Oncology|February 1, 2022
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR AlterationsDavid M Hyman, Ben Tran, Luis Paz-Ares, et al.
The Lancet. Oncology|October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket studyMrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
The New England Journal of Medicine|October 10, 2009
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009Seema Jain, Laurie Kamimoto, Anna M Bramley, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Pageof 13